Logo image of OFAL

OFA GROUP (OFAL) Stock Fundamental Analysis

NASDAQ:OFAL - Nasdaq - KYG6713S1066 - Common Stock - Currency: USD

1.5  -0.26 (-14.77%)

After market: 1.5 0 (0%)

Fundamental Rating

1

Taking everything into account, OFAL scores 1 out of 10 in our fundamental rating. OFAL was compared to 80 industry peers in the Professional Services industry. OFAL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OFAL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OFAL had negative earnings in the past year.
OFAL had a negative operating cash flow in the past year.
OFAL Yearly Net Income VS EBIT VS OCF VS FCFOFAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 100K -100K -200K

1.2 Ratios

With a Return On Assets value of -18.58%, OFAL is not doing good in the industry: 83.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.58%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OFAL Yearly ROA, ROE, ROICOFAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 50 -50

1.3 Margins

OFAL has a Gross Margin (32.98%) which is comparable to the rest of the industry.
OFAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OFAL Yearly Profit, Operating, Gross MarginsOFAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 10 -10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

OFAL has about the same amout of shares outstanding than it did 1 year ago.
OFAL has a worse debt/assets ratio than last year.
OFAL Yearly Shares OutstandingOFAL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M 10M
OFAL Yearly Total Debt VS Total AssetsOFAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100K 200K 300K 400K

2.2 Solvency

An Altman-Z score of 22.00 indicates that OFAL is not in any danger for bankruptcy at the moment.
OFAL's Altman-Z score of 22.00 is amongst the best of the industry. OFAL outperforms 98.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 22
ROIC/WACCN/A
WACCN/A
OFAL Yearly LT Debt VS Equity VS FCFOFAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200K -200K 400K

2.3 Liquidity

A Current Ratio of 1.95 indicates that OFAL should not have too much problems paying its short term obligations.
The Current ratio of OFAL (1.95) is better than 72.50% of its industry peers.
OFAL has a Quick Ratio of 1.95. This is a normal value and indicates that OFAL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.95, OFAL is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95
OFAL Yearly Current Assets VS Current LiabilitesOFAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100K 200K 300K

More info and screens

0

3. Growth

3.1 Past

The earnings per share for OFAL have decreased strongly by -153.85% in the last year.
OFAL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -51.73%.
EPS 1Y (TTM)-153.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-213.04%
Revenue 1Y (TTM)-51.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-53.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OFAL Yearly Revenue VS EstimatesOFAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OFAL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OFAL Price Earnings VS Forward Price EarningsOFAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFAL Per share dataOFAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OFAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OFA GROUP

NASDAQ:OFAL (8/15/2025, 8:00:02 PM)

After market: 1.5 0 (0%)

1.5

-0.26 (-14.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.88M
AnalystsN/A
Price TargetN/A
Short Float %4.08%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.04
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.98%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z 22
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-213.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-51.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-53.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-153.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.45%
OCF growth 3YN/A
OCF growth 5YN/A